FDA — authorised 14 September 2018
- Application: NDA209566
- Marketing authorisation holder: MMT
- Local brand name: SEIZALAM
- Indication: SOLUTION — INTRAMUSCULAR
- Status: approved
FDA authorised Seizalam on 14 September 2018
Yes. FDA authorised it on 14 September 2018.
MMT holds the US marketing authorisation.